Patents by Inventor John Coley
John Coley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 7464753Abstract: A microcontroller system for oil and gas wells using a plunger lift device, which responds to the variations in well production and operation. The system requires minimal operator input, and is able to calculate the operational cycles and adjustments to maximize well production and maintain environmental safety using non-linear artificial intelligence processes.Type: GrantFiled: April 3, 2006Date of Patent: December 16, 2008Assignee: Time Products, Inc.Inventors: Arthur F. White, John Coley
-
Publication number: 20080248494Abstract: A method and test device for differentiating between states of an analyte that can exist in different forms, such as follicle stimulating hormone (FSH). The method or test device uses two contemporaneous assays, the first of which does not differentiate between the two analyte states and the second of which does, and the assay results are compared. A novel pair of anti-FSH monoclonal antibodies that can be used together in a sandwich-format assay to differentiate pre-menopausal and post-menopausal FSH samples is disclosed.Type: ApplicationFiled: February 25, 2008Publication date: October 9, 2008Inventors: Lorraine D. Butlin, John Coley, Stephen J. Eida, Mohamed M. Gani
-
Patent number: 7410768Abstract: A method and test device for differentiating between states of an analyte that can exist in different forms, such as follicle stimulating hormone (FSH). The method or test device uses a pair of specific binding agents, especially monoclonal antibodies, in two assays for the same analyte. The assays, applied to contemporaneous samples, differ from one another in format, one being a two step assay and the other being one step. A novel pair of anti-FSH monoclonal antibodies that can be used together in two such assays to differentiate pre-menopausal and post-menopausal FSH samples is disclosed.Type: GrantFiled: April 3, 2001Date of Patent: August 12, 2008Assignee: Inverness Medical Switzerland GmbHInventors: Lorraine D. Butlin, John Coley, Stephen J. Eida, Mohamed M. Gani
-
Publication number: 20080168749Abstract: An apparatus for sorting and packaging vinyl siding panels. The apparatus comprises a panel receiving section for positioning in line with a panel extrusion line, pins for inverting and stacking the panels atop each other with the pins being coupled to a frame supporting the panel receiving section and situated below the panel receiving section, a panel accumulation section situated below the panel receiving section and the pins, and a mechanism means, preferably a ram mechanism, situated at a first end of the panel accumulation section for pushing the panels from the panel accumulation section and into a container, such as a pre-made carton, situated at a second end of the panel accumulation section that is opposite the first end. The apparatus substantially reduces ergonomic issues associated with the current apparatus for packaging vinyl siding panels and substantially increases the vinyl siding panel extrusion rate. A method is also disclosed.Type: ApplicationFiled: January 17, 2007Publication date: July 17, 2008Inventors: Joseph Regelski, Michael Anderson, Mark Strozensky, Craig Galloway, John Coley, Gregg Greg Jackson
-
Publication number: 20070261845Abstract: A microcontroller system for oil and gas wells using a plunger lift device, which responds to the variations in well production and operation. The system requires minimal operator input, and is able to calculate the operational cycles and adjustments to maximize well production and maintain environmental safety using non-linear artificial intelligence processes.Type: ApplicationFiled: April 3, 2006Publication date: November 15, 2007Applicant: Time Products, Inc.Inventors: Arthur White, John Coley
-
Publication number: 20070092445Abstract: Methods for assessing the ovarian reserve of a female subject may include (a) testing the concentration of follicle stimulating hormone (FSH) in urine samples obtained from the subject, the samples being obtained on at least two different days during a first menstrual cycle in the subject; (b) testing the concentration of FSH in further urine samples, the further samples being obtained on at least two different days during one or more subsequent menstrual cycles in the subject, which days may be the same as, or different from, the days on which samples are obtained in step (a); (c) comparing the FSH test results obtained from the subject with a reference value calculated from a menopausal or non-menopausal control population; and, (d) based at least partly on the comparison, making an assessment of the subject's ovarian reserveType: ApplicationFiled: September 11, 2006Publication date: April 26, 2007Inventors: John Coley, Fernando Miro, Jayne Ellis, Paul Henry Mundill
-
Publication number: 20050130311Abstract: Disclosed is a method of detecting a retarded cycle in a human female subject experiencing same, the method comprising the steps of obtaining a sample of body fluid from the subject on each of a plurality of, but not less than three, days; testing each of the plurality of samples to determine the concentration therein of at least one analyte of significance in the ovulatory cycle; comparing a result determined from said testing with a predetermined threshold value; and, if said determined result is different from the threshold value; declaring the cycle, during which the samples were taken, to be a retarded cycle.Type: ApplicationFiled: September 18, 2002Publication date: June 16, 2005Inventors: John Coley, Fernando Miro, Laurence Aspinall, Peter Murray, Anthony Dadd, Zhi Zhang, Paul Mundill
-
Publication number: 20040235183Abstract: Disclosed is a method of assessing the fertility status of a human female subject, the method comprising the steps of: (a) testing the concentration of FSH in each of a plurality of urine samples obtained from the subject, each sample being obtained on a different day of a first menstrual cycle in the subject; (b) testing the concentration of FSH in each of plurality of urine samples, each sample being obtained on a different day in one or more subsequent menstrual cycles in the subjects; (c) comparing the FSH test results obtained from the subject with a reference value from a control population; and, (d) based at least partly on the comparison, making an assessment of the fertility status of the subject.Type: ApplicationFiled: July 8, 2004Publication date: November 25, 2004Inventors: John Coley, Fernando Miro, Jayne Ellis, Paul Henry Charles Mundill
-
Publication number: 20040219621Abstract: A method and test device for differentiating between states of an analyte that can exist in different forms, such as follicle stimulating hormone (FSH). The method or test device uses two contemporaneous assays, the first of which does not differentiate between the two analyte states and the second of which does, and the assay results are compared. A novel pair of anti-FSH monoclonal antibodies that can be used together in a sandwich-format assay to differentiate pre-menopausal and post-menopausal FSH samples is disclosed.Type: ApplicationFiled: February 17, 2004Publication date: November 4, 2004Inventors: Lorraine D. Butlin, John Coley, Stephen J. Eida, Mohamed M. Gani
-
Patent number: 6585663Abstract: A method and test kit for providing contraceptive advice during the human ovulation cycle, involving simply the measurement of urinary lutenising hormone (LH) concentration on a daily basis during the early phase of the cycle until the LH surge indicative of ovulation is detected, together with calender means to advise the user to abstain from unprotected intercourse during a time interval commencing not later than a predetermined first day of LH testing and ending at least 2 days following the day of LH surge detection.Type: GrantFiled: August 1, 1997Date of Patent: July 1, 2003Assignee: Inverness Medical Switzerland GmbHInventors: John Coley, Paul J Davis, Stephanie J Senior
-
Patent number: 6454726Abstract: A method of monitoring the status of a current ovulation cycle of an individual human female subject, involving testing of the body fluid concentration of an analyte of significance in relation to the status of the ovulation cycle, such as urinary E3G, during at least part of the pre-ovulation phase of the current ovulation cycle of the individual subject, and identification from the results of such testing an analyte concentration change indicative of imminent ovulation, relative to an analyte concentration reference value that has been adapted to the individual human subject on the basis of analyte concentration test data obtained from the individual human subject during one or more previous ovulation cycles.Type: GrantFiled: October 10, 1996Date of Patent: September 24, 2002Assignee: Inverness Medical Switzerland GmbHInventors: Michael Catt, John Coley, Paul J Davis
-
Publication number: 20020045273Abstract: A method and test device for differentiating between states of an analyte that can exist in different forms, such as follicle stimulating hormone (FSH). The method or test device uses a pair of specific binding agents, especially monoclonal antibodies, in two assays for the same analyte. The assays, applied to contemporaneous samples, differ from one another in format, one being a two step assay and the other being one step. A novel pair of anti-FSH monoclonal antibodies that can be used together in two such assays to differentiate pre-menopausal and post-menopausal FSH samples is disclosed.Type: ApplicationFiled: April 3, 2001Publication date: April 18, 2002Inventors: Lorraine D. Butlin, John Coley, Stephen J. Eida, Mohamed M. Gani
-
Publication number: 20020042149Abstract: A method and test device for differentiating between states of an analyte that can exist in different forms, such as follicle stimulating hormone (FSH). The method or test device uses two contemporaneous assays, the first of which does not differentiate between the two analyte states and the second of which does, and the assay results are compared. A novel pair of anti-FSH monoclonal antibodies that can be used together in a sandwich-format assay to differentiate pre-menopausal and post-menopausal FSH samples is disclosed.Type: ApplicationFiled: April 3, 2001Publication date: April 11, 2002Inventors: Lorraine D. Butlin, John Coley, Stephen J. Eida, Mohamed M. Gani
-
Patent number: 6234974Abstract: A method of monitoring the status of a current ovulation cycle of an individual human female subject, involving testing of the body fluid concentration of an analyte of significance in relation to the status of the ovulation cycle, such as urinary E3G, during at least part of the pre-ovulation phase of the current ovulation cycle of the individual subject, and identification from the results of such testing an analyte concentration change indicative of imminent ovulation, relative to an analyte concentration reference value that has been adapted to the individual human subject on the basis of analyte concentration test data obtained from the individual human subject during one or more previous ovulation cycles.Type: GrantFiled: December 24, 1996Date of Patent: May 22, 2001Assignee: Unilever Patent Holdings B.V.Inventors: Michael Catt, John Coley, Paul J Davis
-
Patent number: 5657762Abstract: A method of monitoring the ovulation cycle of a female mammal, involving regular measurement of basal body temperature throughout a current ovulation cycle and occasional measurement of the level of at least one urinary component of significance in the cycle, the measurement of the urinary component being conducted at predetermined stages in the cycle to check that the level is consistent with a predicted level and thus confirm that the cycle as a whole is consistent with a prediction.Type: GrantFiled: December 17, 1990Date of Patent: August 19, 1997Assignee: Unilever Patent Holdings B.V.Inventors: John Coley, Paul James Davis, Philip Porter
-
Patent number: 5467778Abstract: A method of monitoring the status of a current ovulation cycle of an individual human female subject, involving testing of the body fluid concentration of an analyte of significance in relation to the status of the ovulation cycle, such as urinary E3G, during at least part of the pre-ovulation phase of the current ovulation cycle of the individual subject, and identification from the results of such testing an analyte concentration change indicative of imminent ovulation, relative to an analyte concentration reference value that has been adapted to the individual human subject on the basis of analyte concentration test data obtained from the individual human subject during one or more previous ovulation cycles.Type: GrantFiled: August 20, 1993Date of Patent: November 21, 1995Assignee: Unilever Patent Holdings B.V.Inventors: Michael Catt, John Coley, Paul J. Davis
-
Patent number: 4980298Abstract: A device for carrying out chemical or clinical testing of a liquid sample, for example a urine sample, by a specific binding assay, said device comprising a test compoenent (2) which has a sensitised solid surface (2a) carrying an immobilized component of a specific binding pair relevant to the essay, and a handling piece (1), and characterized in that the test component (2) bearing the sensitized surface (2a) is removably mounted in spaced relationship with a removably mounted accessory component (4) carrying an accessory solid surface (5), and in that there is a space (4a) between the sensitized surface (2a) and the removable accessory component (4) to act as a container for sample liquid, so that when the device is contacted with a sample liquid source or immersed in liquid which is to provide the test sample, liquid of the sample can enter the space (4a) to contact the sensitized surface (2a), and the accessory surface (5) acts to retain and contain sample liquid in contact with the sensitized surface (2aType: GrantFiled: June 20, 1989Date of Patent: December 25, 1990Assignee: Unilever Patent Holdings B.V.Inventors: Anthony Blake, John Coley, Ronald Smith
-
Patent number: 4742011Abstract: A device for carrying out chemical or clinical testing of a liquid sample, for example a urine sample, by a specific binding assay, said device comprising a test component (2) which has a sensitized solid surface (2a) carrying an immobilized component of a specific binding pair relevant to the assay, and a handling piece (1), and characterized in that the test component (2) bearing the sensitized surface (2a) is removably mounted in spaced relationship with a removably mounted accessory component (4) carrying an accessory solid surface (5), and in that there is a space (4a) between the sensitized surface (2a) and the removable accessory component (4) to act as a container for sample liquid, so that when the device is contacted with a sample liquid source or immersed in liquid which is to provide the test sample, liquid of the sample can enter the space (4a) to contact the sensitized surface (2a), and the accessory surface (5) acts to retain and contain sample liquid in contact with the sensitized surface (2a)Type: GrantFiled: May 30, 1985Date of Patent: May 3, 1988Assignee: Unilever Patent Holdings B.V.Inventors: Anthony Blake, John Coley, Ronald Smith